New Weight Loss Pills Qsymia available by prescription
The U.S. Food and Drug Administration approved two new weight loss medications in 2012, extending the available options for medically obese patients on reduced calorie diet programs.
Obesity is defined as having a body-mass index greater than 30.
Although both have been approved this year, they are different weight loss drugs and work differently to promote losing weight in obese patients.
Qnexa now Qsymia
Qsymia (formerly Qnexa) is a blend of well-established weight loss drug phentermine along with extended release topiramate, another medication approved for other uses. Phentermine acts an appetite suppressant by stimulating Leptin release in the body.
Qsymia is available now for prescription by weight loss doctors.
About Belviq (lorcaserin hydrochloride)
Belviq works by activating Serotonin, a brain chemical signal derived from Tryptophan, in low dose. It is not yet available to patients as it requires additional coordination as it will be classified a controlled substance.
Both of these medications achieve results by suppressing appetite albeit via targeting different biological pathways.
For more information about medical weight loss, you are welcome to contact Dr Aron’s office at 718-491-5525 and schedule a free consultation.
References & further Reading
- Oksana Aron MD, Weight Loss Medications
- Oksana Aron MD, Qsymia, Another Anti-Obesity Diet Drug Approved by FDA, July 2012
- Oksana Aron MD, New Diet Drug BELVIQ Approved by FDA, June 2012
- U.S. Food & Drug Administration, FDA approves weight-management drug Qsymia, July 2012
- WebMD, Weight Loss Pill Qsymia Now for Sale, Sept 2012
- WebMD, Belviq, Qsymia: New Weight Loss Drugs Compared, July 18, 2012
- Vivius, Indication and Usage
- Oksana Aron MD, Weight Loss Drug Qnexa Wins Support, February 2012